Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-03-000623
Filing Date
2003-07-31
Accepted
2003-07-31 11:54:45
Documents
2
Period of Report
2003-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o10407ae6vk.htm 6-K 12770
3 GRAPHIC o10407ao1040701.gif GRAPHIC 3109
  Complete submission text file 0001130319-03-000623.txt   17387
Mailing Address
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 03813629
SIC: 2834 Pharmaceutical Preparations